Victrex (LON:VCT – Get Free Report) had its price target decreased by JPMorgan Chase & Co. from GBX 725 to GBX 625 in a research report issued to clients and investors on Wednesday,London Stock Exchange reports. The brokerage presently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 10.98% from the stock’s previous close.
Separately, Deutsche Bank Aktiengesellschaft decreased their price target on shares of Victrex from GBX 850 to GBX 780 and set a “hold” rating on the stock in a research note on Tuesday, December 2nd. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of GBX 756.25.
Victrex Price Performance
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
See Also
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
